The fully self-contained laboratory tablet coating machine requires only power and compressed air to operate.
All contact parts are in 316L stainless steel, or US FDA approved materials.
The unit can be used for the development of coating processes, and also for marketing and colour matching.
The system uses a 5.7in colour touchscreen to control all operations. Heat recovery is available from all heat sources reducing energy requirements and exhaust air temperature.
Batch sizes for drum coating are from 4kg down to 400g, but there is an option to convert the system to a Wurster Column and coat batches down to 40g.
Maintenance is kept to a minimum with quick-release operator parts and push-in connectors that eliminate the need for special tools. Rapid strip down and re-assembly saves time between batches and all parts can be cleaned ultrasonically.
Tablet coating machine for small batches
The CSI Technicota LAB coats batches down to 40g when converted to a Wurster Column
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Measuring tablet film-coating robustness beyond a single setpoint
Read moreMeeting coating setpoints can hide variation between tablets. Linking core attributes, spray, drying and sampling evidence supports reliable scale-up and a defensible operating window
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part V)
As therapies grow more complex, manufacturers must build commercial-scale thinking into early development, focus on meaningful monitoring and favour simplicity to keep production predictable
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part IV)
Real-time monitoring, digital-first platforms and early scalability planning can help manufacturers to maintain quality, flexibility and speed as dosage forms become more sophisticated
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part III)
Early collaboration, specialist purification and carefully targeted investment help manufacturers to bridge development and commercial production, improving process robustness, efficiency and dependable supply